FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073208829> ?p ?o ?g. }

• W2073208829 endingPage "2198" @default.
• W2073208829 startingPage "2187" @default.
• W2073208829 abstract "Objective. To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide (CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's granulomatosis (WG). Methods. Patients with newly diagnosed systemic WG were enrolled in a prospective, randomized trial. At the time of diagnosis, prior to randomization, every patient received a daily injection of methylprednisolone for 3 days, followed by daily oral prednisone (1 mg/kg/day) and a 0.7-gm/m2 pulse of CYC. Patients were then randomly assigned to receive either prednisone plus intravenous pulse CYC (group A) or prednisone plus oral CYC (group B) as first-line treatment. CYC was given for at least 1 year and was then progressively tapered and discontinued. Results. Fifty patients were included in the study: 27 in group A and 23 in group B. At 6 months, 24 group A patients (88.9%) were in remission, versus 18 group B patients (78.3%). At the end of the trial, 18 group A patients (66.7%) and 13 group B patients (56.5%) were in remission. In group A, 66.7% of the patients experienced side effects, versus 69.6% in group B. Infectious side effects were significantly more frequent in group B (69.6%) than in group A (40.7%) (P < 0.05). The incidence of Pneumocystis carinii pneumonia was higher in oral CYC-treated patients (30.4%) than in pulse CYC-treated patients (11.1%). Nine group A patients (33.3%) and 10 group B patients (43.5%) died. Actuarial curves showed that relapses were significantly more frequent in group A (59.2%) than in group B (13%) (P = 0.02). Conclusion. Our results indicate that pulse CYC is as effective as oral CYC in achieving initial remission of WG and is associated with fewer side effects and lower mortality. However, in the long term, treatment with pulse CYC does not maintain remission or prevent relapses as well as oral CYC." @default.
• W2073208829 created "2016-06-24" @default.
• W2073208829 creator A5002721139 @default.
• W2073208829 creator A5017139951 @default.
• W2073208829 creator A5018486655 @default.
• W2073208829 creator A5021139470 @default.
• W2073208829 creator A5031175041 @default.
• W2073208829 creator A5031416402 @default.
• W2073208829 creator A5032474848 @default.
• W2073208829 creator A5035284983 @default.
• W2073208829 creator A5041950808 @default.
• W2073208829 creator A5042233680 @default.
• W2073208829 creator A5042672118 @default.
• W2073208829 creator A5049368595 @default.
• W2073208829 creator A5050352531 @default.
• W2073208829 creator A5052594138 @default.
• W2073208829 creator A5058608604 @default.
• W2073208829 creator A5062415416 @default.
• W2073208829 creator A5069944774 @default.
• W2073208829 creator A5076713502 @default.
• W2073208829 creator A5081920170 @default.
• W2073208829 creator A5082190748 @default.
• W2073208829 date "1997-12-01" @default.
• W2073208829 modified "2023-10-14" @default.
• W2073208829 title "A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis" @default.
• W2073208829 cites W1957383308 @default.
• W2073208829 cites W1984702041 @default.
• W2073208829 cites W1998042872 @default.
• W2073208829 cites W2008828986 @default.
• W2073208829 cites W2011309580 @default.
• W2073208829 cites W2018087829 @default.
• W2073208829 cites W2037557937 @default.
• W2073208829 cites W2038252730 @default.
• W2073208829 cites W2055896786 @default.
• W2073208829 cites W2068920227 @default.
• W2073208829 cites W2070225381 @default.
• W2073208829 cites W2086003187 @default.
• W2073208829 cites W2098937807 @default.
• W2073208829 cites W2109207289 @default.
• W2073208829 cites W2134305598 @default.
• W2073208829 cites W2140137202 @default.
• W2073208829 cites W2142627411 @default.
• W2073208829 cites W2159433259 @default.
• W2073208829 cites W2162725007 @default.
• W2073208829 cites W2171950933 @default.
• W2073208829 cites W2312254946 @default.
• W2073208829 cites W2420746134 @default.
• W2073208829 cites W2563968543 @default.
• W2073208829 cites W4293241248 @default.
• W2073208829 doi "https://doi.org/10.1002/art.1780401213" @default.
• W2073208829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9416856" @default.
• W2073208829 hasPublicationYear "1997" @default.
• W2073208829 type Work @default.
• W2073208829 sameAs 2073208829 @default.
• W2073208829 citedByCount "467" @default.
• W2073208829 countsByYear W20732088292012 @default.
• W2073208829 countsByYear W20732088292013 @default.
• W2073208829 countsByYear W20732088292014 @default.
• W2073208829 countsByYear W20732088292015 @default.
• W2073208829 countsByYear W20732088292016 @default.
• W2073208829 countsByYear W20732088292017 @default.
• W2073208829 countsByYear W20732088292018 @default.
• W2073208829 countsByYear W20732088292019 @default.
• W2073208829 countsByYear W20732088292020 @default.
• W2073208829 countsByYear W20732088292021 @default.
• W2073208829 countsByYear W20732088292022 @default.
• W2073208829 countsByYear W20732088292023 @default.
• W2073208829 crossrefType "journal-article" @default.
• W2073208829 hasAuthorship W2073208829A5002721139 @default.
• W2073208829 hasAuthorship W2073208829A5017139951 @default.
• W2073208829 hasAuthorship W2073208829A5018486655 @default.
• W2073208829 hasAuthorship W2073208829A5021139470 @default.
• W2073208829 hasAuthorship W2073208829A5031175041 @default.
• W2073208829 hasAuthorship W2073208829A5031416402 @default.
• W2073208829 hasAuthorship W2073208829A5032474848 @default.
• W2073208829 hasAuthorship W2073208829A5035284983 @default.
• W2073208829 hasAuthorship W2073208829A5041950808 @default.
• W2073208829 hasAuthorship W2073208829A5042233680 @default.
• W2073208829 hasAuthorship W2073208829A5042672118 @default.
• W2073208829 hasAuthorship W2073208829A5049368595 @default.
• W2073208829 hasAuthorship W2073208829A5050352531 @default.
• W2073208829 hasAuthorship W2073208829A5052594138 @default.
• W2073208829 hasAuthorship W2073208829A5058608604 @default.
• W2073208829 hasAuthorship W2073208829A5062415416 @default.
• W2073208829 hasAuthorship W2073208829A5069944774 @default.
• W2073208829 hasAuthorship W2073208829A5076713502 @default.
• W2073208829 hasAuthorship W2073208829A5081920170 @default.
• W2073208829 hasAuthorship W2073208829A5082190748 @default.
• W2073208829 hasBestOaLocation W20732088291 @default.
• W2073208829 hasConcept C126322002 @default.
• W2073208829 hasConcept C141071460 @default.
• W2073208829 hasConcept C168563851 @default.
• W2073208829 hasConcept C188816634 @default.
• W2073208829 hasConcept C204243189 @default.
• W2073208829 hasConcept C2776694085 @default.
• W2073208829 hasConcept C2776755627 @default.
• W2073208829 hasConcept C2776804153 @default.
• W2073208829 hasConcept C2777785397 @default.

• next